Maki Umemiya
Papers
1
Total Citations
2
H-Index
1
About
Maki Umemiya is a clinician-researcher focused on hereditary cancer syndromes, particularly Lynch syndrome—an autosomal dominant disorder caused by germline pathogenic variants in DNA mismatch repair genes that predisposes individuals to multi-organ cancers. Her work centers on improving early detection and surveillance strategies for at-risk patients. In her notable 2023 case report, "Endometrial Cancer Diagnosed at an Early Stage during Lynch Syndrome Surveillance," Umemiya demonstrated the critical value of annual transvaginal ultrasonography and endometrial biopsy in identifying endometrial cancer at treatable stages. This contribution underscores her commitment to translating genetic risk knowledge into actionable clinical protocols. While her citation count is still building—reflecting the recent nature of her work—her research has immediate implications for oncologists, genetic counselors, and patients navigating Lynch syndrome management. Umemiya’s findings advocate for rigorous, evidence-based surveillance to reduce cancer mortality in hereditary cancer populations, positioning her as an emerging voice in precision oncology and cancer genetics.
Research Focus
Key Achievements
Top Papers
- 1